Home>>Modified Nucleotides>>N1-Me-pUTP,100mM Sodium Solution

N1-Me-pUTP,100mM Sodium Solution (Synonyms: 1-Methylpseudouridine-5′-triphosphate)

Catalog No.GB20016

N1-Me-pUTP,100mM Sodium Solution (1-Methylpseudouridine-5′-triphosphate) is a nucleobase-modified nucleotide, used for synthesizing mRNA with reduced immunogenicity and improved stability.

Products are for research use only. Not for human use. We do not sell to patients.

N1-Me-pUTP,100mM Sodium Solution Chemical Structure

Cas No.: 1428903-59-6

Size Price Stock Qty
1mL
$480.00
In stock
100mL Please Inquire Please Inquire
500mL
$0.10
Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

N1-Methylpseudo-UTP (N1-Me-pUTP, m1ψ) is a methyl modification of naturally occurring pseudouridine (pseudo-UTP, pUTP), resulting from the N1-specific pseudouridine present in archaea and eukaryotes It is catalyzed by glycoside methyltransferase Nepl[1]. N1-Me-pUTP is a substitute for uridine (U) in RNA therapies and vaccines, which can effectively enhance RNA stability while reducing anti-RNA immune responses[2].

References:
[1]. Callum J C Parr, et al.N 1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells. 2020 Apr 6;48(6):e35. doi: 10.1093/nar/gkaa070.
[2]. Pedro Morais, Hironori Adachi, Yi-Tao Yu.The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines. 2021 Nov 4;9:789427. doi: 10.3389/fcell.2021.789427.

Reviews

Review for N1-Me-pUTP,100mM Sodium Solution

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N1-Me-pUTP,100mM Sodium Solution

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.